Navigation Links
Rosetta Genomics Announces Conference Call and Webcast of Second Quarter Financial Results
Date:8/12/2008

REHOVOT, Israel and JERSEY CITY, New Jersey, August 12 /PRNewswire-FirstCall/ -- Rosetta Genomics (Nasdaq: ROSG), today announced it will release first quarter financial results on August 19, 2008, before the U.S. markets open. Rosetta Genomics will host a conference call with a simultaneous webcast to discuss these results at 8:30 a.m. ET on Tuesday, August 19.

To access the live conference call, U.S. and Canadian participants may dial 1-866-966-5335; international participants may dial +44-20-3023-4460. To access the 24-hour audio replay, U.S. and Canadian participants may dial 1-866-583-1035; international participants may dial 44-20-8196-1998. The access code for the replay is 181543#. The replay will be available until August 26, 2008.

A live audio webcast of the call will also be available on the "Investors" section of the company's website, http://www.RosettaGenomics.com. An archived webcast will be available on the Company's website approximately two hours after the event, and will be archived for 30 days thereafter.

About Rosetta Genomics

Rosetta Genomics (Nasdaq: ROSG) is a leader in the field of microRNAs. Founded in 2000, the company's integrative research platform combining bioinformatics and state-of-the-art laboratory processes has led to the discovery of hundreds of biologically validated novel human microRNAs. Building on its strong IP position and proprietary platform technologies, Rosetta Genomics is working on th
'/>"/>

SOURCE Rosetta Genomics Ltd
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Rosetta Genomics Completes Acquisition of Parkway Clinical Laboratories Inc.
2. Rosetta Genomics to Present at Collins Stewart Fourth Annual Growth Conference
3. Rosetta Genomics Announces Plans to Recruit a New Chief Financial Officer
4. Rosetta Genomics Announces Three New Diagnostic Tests to Enter Development
5. Rosetta Genomics Executes Binding Term Sheet to Acquire U.S. CLIA-Certified Lab to Expedite Commercialization of Diagnostic Tests
6. /C O R R E C T I O N -- Rosetta Genomics Ltd/
7. Rosetta Genomics Reports First Quarter 2008 Financial Results
8. Rosetta Genomics Announces Conference Call and Webcast of First Quarter Financial Results
9. Rosetta Genomics Announces Expansion of its MicroRNA Intellectual Property Estate
10. Rosetta Genomics to Present Multiple Posters at the Annual American Association of Cancer Research (AACR) Conference
11. Accurate Identification of Tumor Origin Using MicroRNAs is Published by Rosetta Genomics Scientists and Collaborators in Nature Biotechnology

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...AYWARD, Calif., Nov. 6 Intarcia Th... on its ITCA 650 (DUROS® continuous delivery ...diabetes at the Ninth Annual Diabetes Technology M...www.newscom.com/cgi-bin/prnh/20050301/SFTU126LOGO ...atide Via ITCA 650 Lowers Plasma Glucose, HbA1c an...
(Date:11/5/2009)...ELLINGTON, Colo., Nov. 5 The endan...ns in the western U.S. This rare carnivore feeds ...ptible to plague and often entire population die-o...Service (FWS) has implemented a ferret breeding pr...ets into their formerly native habitat. Unfortuna...
(Date:11/5/2009)...onference Call on Thursday, November 5, 2009 at 4:...VER Nov. 5 /PRNewswire-FirstCall/ - OncoGenex Phar...NASDAQ: OGXI ) today reported unaudited financial...ed September 30, 2009 and reviewed the Company,s h... following consolidated results reflect the operat...
(Date:11/5/2009)...ORT WORTH, Texas, Nov. 5 ...unced today that it has entered into a Letter of I... Virtual Health Technologies, Inc. (OTC Bulletin B... $1,000,000 in cash and debt, 4,000,000 shares of ...d by WNDM on the Veriscrip technology being acquir...
Breaking Biology Technology:Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 2OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 3
...ife,s Clinical Flexibility, Expanding Physicians ...Cancer, SUNNYVALE, Calif., April 8, 2008 Accuray... the field of radiosurgery,announced today that a ...ational Journal of Radiation Oncology*Biology*Phys...es that the CyberKnife(R) Robotic,Radiosurgery Sys...
...oard of Molecular Vision today,announces that disc...tion,of Molecular Vision have now ceased. Acrongen... timetable agreed. Given this, the Board of,Molecu... company are served,by bringing these discussions ...nt shareholder in Molecular Vision, having recentl...
..., 2008 Martek,Biosciences Corporation announced t... District of Maryland has entered a Final Judgment...f the consolidated class action,brought on behalf ... class,action was brought under the federal securi...r things, of violations of Section 10(b) and 20(a)...
Other Biology Technology:CyberKnife Prostate Cancer Planning Study Published in Leading Radiation Oncology Journal 2CyberKnife Prostate Cancer Planning Study Published in Leading Radiation Oncology Journal 3CyberKnife Prostate Cancer Planning Study Published in Leading Radiation Oncology Journal 4Martek Announces Final Judgment and Order of Dismissal in Class Action 2
(Date:11/6/2009)...ROIT, Nov. 6 Auburn Hills, MI-base...will be installing its locker system and patent-pe...t the U.S. Department of Health and Human Services...hesda, MD. The locker system will support the NIH...tecting our nation,s medical research agency. The...
(Date:11/5/2009)...ional Association of Biology Teachers (NABT) will ...gical sciences at Naugatuck Valley Community Colle... Evolution Education Award during the NABT annual ...14 November 2009 in Denver, Colorado. , The Evol...an Institute of Biological Sciences,(AIBS) and Bi...
(Date:11/5/2009)...ate University has been awarded a training grant i... Foundation under its Integrative Graduation Educa...s the first IGERT grant to be awarded to Kent Stat...ecovery and Reinvestment Act of 2009, runs through...ocuses on environment aquatic resource sensing (EA...
Breaking Biology News(10 mins):Biologists, educators recognize excellence in evolution education 2Kent State receives $2.7 million NSF training grant for environmental aquatic resource sensing 2Medication effective for acute liver failure in early stages of disease 59115 1Medication effective for acute liver failure in early stages of disease 59115 2Inoperable Colon Cancer Resolved After Four Months of New Treatment 59114 1Inoperable Colon Cancer Resolved After Four Months of New Treatment 59114 2Inoperable Colon Cancer Resolved After Four Months of New Treatment 59114 3Stater Bros Charities Collects 24328 000 for the Cure in I Believe Walk Over 6 000 Participate 59112 1Stater Bros Charities Collects 24328 000 for the Cure in I Believe Walk Over 6 000 Participate 59112 2
...nger than steel and more elastic than rubber: spid...tance to tearing, and toughness. Spider silk would...al and technical applications, and researchers are...and imitating their technique. A team lead by Thom...has now made a step in the right direction. As the...
...rprising finding by a team of University of Georgi...biotics on poultry farms will do little ?if anythi...ia that have the potential to threaten human healt... of Veterinary Medicine, and her colleagues have f... and even those raised under pristine laboratory c...
...t has ways to battle the tiny, red wormlike insect...y crops worldwide, but the Hessian fly larvae that...nt defenses. , Purdue University and USDA-Agricult...he insect have identified Hessian fly genes that n...f from the munching larvae. The researchers report...
Other Biology News:Fascinating spider silk 2Study finds antibiotic resistance in poultry even when antibiotics were not used 2Study finds antibiotic resistance in poultry even when antibiotics were not used 3Scientists find genes involved in the battle between Hessian flies and wheat 2Scientists find genes involved in the battle between Hessian flies and wheat 3
...), fosmid (40kb), and large plasmid insert (10-20k...C vector. On command 20-50 fold copy amplification...tion. Available with blue-white screening (pEZ BAC...e highest insert stability. Kits include electroco...
Goat Anti-MAGP-2 (C-19) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
...ynthetic peptide derived from the C-terminal regio...fic for the junctophilin-2 protein. Reactivity: M...ogenates frozen mouse skeletal muscle tissues). A...(froz) ImmunofluorescenceStorage: Store at -20C fo...
Mouse Anti-TGF-beta 2 Monoclonal Antibody, Unconjugated, Clone 8607 from R&D Systems
Biology Products: